Page last updated: 2024-08-26

propionylcarnitine and Impotence

propionylcarnitine has been researched along with Impotence in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonella Bertozzi, M; Antonini, G; Ashraf Virmani, M; Dinelli, N; Gentile, V; Koverech, A; Rizzo, C	1
Canfield, SE; Dhir, RR; Lin, HC; Wang, R	1
De Larichaudy, J; Di Dato, C; Gianfrilli, D; Giannetta, E; Graziadio, C; Isidori, AM; Lauretta, R; Lenzi, A; Pozza, C	1
Di Silverio, F; Gentile, V; Koverech, A; Prigiotti, G; Vicini, P	1
Cavallini, G; Koverech, A; Modenini, F; Vitali, G	1
Buchetti, B; Fallarino, M; Gandini, L; Gatti, A; Jannini, EA; Lenti, L; Lenzi, A; Mandosi, E; Morano, S; Sensi, M; Tiberti, C	1
Salonia, A	1
Pickard, R	1

Reviews

1 review(s) available for propionylcarnitine and Impotence

Article	Year
Combination therapy for erectile dysfunction: an update review. Asian journal of andrology, 2011, Volume: 13, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Carnitine; Combined Modality Therapy; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vacuum	2011

Trials

4 trial(s) available for propionylcarnitine and Impotence

Article	Year
Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes. Current medical research and opinion, 2009, Volume: 25, Issue:9 Topics: Arginine; Carnitine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Niacin; Penile Erection; Piperazines; Placebos; Sulfones; Surveys and Questionnaires; Treatment Outcome; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents	2009
Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes. Current medical research and opinion, 2004, Volume: 20, Issue:9 Topics: Carnitine; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones	2004
Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. Urology, 2005, Volume: 66, Issue:5 Topics: Acetylcarnitine; Carnitine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Prostate; Prostatectomy; Purines; Sildenafil Citrate; Sulfones	2005
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. European urology, 2007, Volume: 52, Issue:6 Topics: Aged; Antioxidants; Biomarkers; Carnitine; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Erectile Dysfunction; Glycated Hemoglobin; Humans; Male; Middle Aged; Monocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Reactive Oxygen Species; Sildenafil Citrate; Sulfones	2007

Other Studies

3 other study(ies) available for propionylcarnitine and Impotence

Article	Year
Propionyl-L-carnitine, L-arginine and niacin in sexual medicine: a nutraceutical approach to erectile dysfunction. Andrologia, 2012, Volume: 44 Suppl 1 Topics: Adult; Aged; Arginine; Carnitine; Dietary Supplements; Erectile Dysfunction; Humans; Male; Middle Aged; Niacin	2012
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. European urology, 2007, Volume: 52, Issue:6 Topics: Antioxidants; Carnitine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Monocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones	2007
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. European urology, 2007, Volume: 52, Issue:6 Topics: Antioxidants; Carnitine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones	2007